Cargando…
Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study
The coexistence of a substance use disorder and another mental disorder in the same individual has been called dual disorder or dual diagnosis. This study aimed to examine the prevalence of lifetime dual disorder in individuals with alcohol or cocaine use disorder and their retention in treatment. W...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267195/ https://www.ncbi.nlm.nih.gov/pubmed/35807045 http://dx.doi.org/10.3390/jcm11133760 |
_version_ | 1784743658925326336 |
---|---|
author | Puértolas-Gracia, Beatriz Barbaglia, María Gabriela Gotsens, Mercè Parés-Badell, Oleguer Brugal, María Teresa Torrens, Marta Treviño, Lara Rodríguez-Díaz, Concepción Vázquez-Vázquez, José María Pascual, Alicia Coromina-Gimferrer, Marcela Jiménez-Dueñas, Míriam Oliva, Israel González, Erick Mestre, Nicanor Bartroli, Montse |
author_facet | Puértolas-Gracia, Beatriz Barbaglia, María Gabriela Gotsens, Mercè Parés-Badell, Oleguer Brugal, María Teresa Torrens, Marta Treviño, Lara Rodríguez-Díaz, Concepción Vázquez-Vázquez, José María Pascual, Alicia Coromina-Gimferrer, Marcela Jiménez-Dueñas, Míriam Oliva, Israel González, Erick Mestre, Nicanor Bartroli, Montse |
author_sort | Puértolas-Gracia, Beatriz |
collection | PubMed |
description | The coexistence of a substance use disorder and another mental disorder in the same individual has been called dual disorder or dual diagnosis. This study aimed to examine the prevalence of lifetime dual disorder in individuals with alcohol or cocaine use disorder and their retention in treatment. We conducted a pilot cohort study of individuals (n = 1356) with alcohol or cocaine use disorder admitted to treatment in the public outpatient services of Barcelona (Spain) from January 2015 to August 2017 (followed-up until February 2018). Descriptive statistics, Kaplan–Meier survival curves and a multivariable Cox regression model were estimated. The lifetime prevalence of screening positive for dual disorder was 74%. At 1 year of follow-up, >75% of the cohort remained in treatment. On multivariable analysis, the factors associated with treatment dropout were a positive screening for lifetime dual disorder (HR = 1.26; 95% CI = 1.00–1.60), alcohol use (HR = 1.35; 95% CI = 1.04–1.77), polysubstance use (alcohol or cocaine and cannabis use) (HR = 1.60; 95% CI = 1.03–2.49) and living alone (HR = 1.34; 95% CI = 1.04–1.72). Lifetime dual disorder is a prevalent issue among individuals with alcohol or cocaine use disorders and could influence their dropout from treatment in public outpatient drug dependence care centres, along with alcohol use, polysubstance use and social conditions, such as living alone. We need a large-scale study with prolonged follow-up to confirm these preliminary results. |
format | Online Article Text |
id | pubmed-9267195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92671952022-07-09 Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study Puértolas-Gracia, Beatriz Barbaglia, María Gabriela Gotsens, Mercè Parés-Badell, Oleguer Brugal, María Teresa Torrens, Marta Treviño, Lara Rodríguez-Díaz, Concepción Vázquez-Vázquez, José María Pascual, Alicia Coromina-Gimferrer, Marcela Jiménez-Dueñas, Míriam Oliva, Israel González, Erick Mestre, Nicanor Bartroli, Montse J Clin Med Article The coexistence of a substance use disorder and another mental disorder in the same individual has been called dual disorder or dual diagnosis. This study aimed to examine the prevalence of lifetime dual disorder in individuals with alcohol or cocaine use disorder and their retention in treatment. We conducted a pilot cohort study of individuals (n = 1356) with alcohol or cocaine use disorder admitted to treatment in the public outpatient services of Barcelona (Spain) from January 2015 to August 2017 (followed-up until February 2018). Descriptive statistics, Kaplan–Meier survival curves and a multivariable Cox regression model were estimated. The lifetime prevalence of screening positive for dual disorder was 74%. At 1 year of follow-up, >75% of the cohort remained in treatment. On multivariable analysis, the factors associated with treatment dropout were a positive screening for lifetime dual disorder (HR = 1.26; 95% CI = 1.00–1.60), alcohol use (HR = 1.35; 95% CI = 1.04–1.77), polysubstance use (alcohol or cocaine and cannabis use) (HR = 1.60; 95% CI = 1.03–2.49) and living alone (HR = 1.34; 95% CI = 1.04–1.72). Lifetime dual disorder is a prevalent issue among individuals with alcohol or cocaine use disorders and could influence their dropout from treatment in public outpatient drug dependence care centres, along with alcohol use, polysubstance use and social conditions, such as living alone. We need a large-scale study with prolonged follow-up to confirm these preliminary results. MDPI 2022-06-28 /pmc/articles/PMC9267195/ /pubmed/35807045 http://dx.doi.org/10.3390/jcm11133760 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Puértolas-Gracia, Beatriz Barbaglia, María Gabriela Gotsens, Mercè Parés-Badell, Oleguer Brugal, María Teresa Torrens, Marta Treviño, Lara Rodríguez-Díaz, Concepción Vázquez-Vázquez, José María Pascual, Alicia Coromina-Gimferrer, Marcela Jiménez-Dueñas, Míriam Oliva, Israel González, Erick Mestre, Nicanor Bartroli, Montse Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title | Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title_full | Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title_fullStr | Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title_full_unstemmed | Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title_short | Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study |
title_sort | lifetime dual disorder screening and treatment retention: a pilot cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267195/ https://www.ncbi.nlm.nih.gov/pubmed/35807045 http://dx.doi.org/10.3390/jcm11133760 |
work_keys_str_mv | AT puertolasgraciabeatriz lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT barbagliamariagabriela lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT gotsensmerce lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT paresbadelloleguer lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT brugalmariateresa lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT torrensmarta lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT trevinolara lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT rodriguezdiazconcepcion lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT vazquezvazquezjosemaria lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT pascualalicia lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT corominagimferrermarcela lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT jimenezduenasmiriam lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT olivaisrael lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT gonzalezerick lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT mestrenicanor lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy AT bartrolimontse lifetimedualdisorderscreeningandtreatmentretentionapilotcohortstudy |